Lv52
1000 积分 2024-06-19 加入
Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
3天前
已完结
Defect of MLH1 expression sensitized esophageal squamous cell carcinoma cells to Polθ inhibitor
6天前
已完结
Understanding and overcoming multidrug resistance in cancer
22天前
已完结
Targeting cancer with small-molecule pan-KRAS degraders
1个月前
已完结
Targeted protein degradation: expanding the toolbox
1个月前
已完结
Bridged PROTAC, DNA-based PROTAC and hydrophobic tag technologies for targeted protein degradation
1个月前
已完结
Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications
1个月前
已完结
Targeted protein degradation for cancer therapy
1个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
2个月前
已完结
Cross-priming in cancer immunology and immunotherapy
2个月前
已完结
皖公网安备34019202002308
